의료용 코팅 시장 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical coatings market size was valued at USD 11.67 billion in 2025 and estimated to grow from USD 12.47 billion in 2026 to reach USD 17.35 billion by 2031, at a CAGR of 6.83% during the forecast period (2026-2031).

This report is Segmented by Chemistry (Silicone, Fluoropolymer, and More), Coating Function Type (Antimicrobial, Hydrophilic/Lubricious, and More), Deposition Technology (Chemical Vapor Deposition, Plasma Spray, and More), Application (Medical Device, Implants, and More), and Geography (Asia-Pacific, North America, Europe, South America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Coatings Market Trends and Insights

Growing Awareness of Advanced Medical Treatments

Healthcare practitioners now view surface engineering as a pathway to transform passive devices into active therapeutic systems that deliver drugs, sense biological signals and resist infection. Multifunctional coatings that simultaneously provide antimicrobial protection and bone-integration support in orthopedics exemplify this shift. Academic evidence demonstrating lower revision rates in coated implants is convincing hospitals to pay premium prices, while device makers integrate sensing layers that enable remote patient monitoring.

Surge in Single-Use, Minimally Invasive Devices

Pandemic-era infection-control lessons accelerated the pivot to disposable catheters and surgical tools. Coating suppliers responded with cost-optimized hydrophilic finishes designed for one-time use, eliminating the sterilization burden of re-usable instruments. Ambulatory centers benefit through faster turnover and reduced cross-contamination risk, supporting volume growth in coated disposables.

Raw-Material Price Volatility

Shortages of PTFE and spikes in silicone precursor costs in 2024 forced many coaters to renegotiate supply contracts, delay shipments and raise prices. Smaller providers lacking hedging capacity lost share to vertically integrated rivals. Although larger players absorbed shocks through inventory buffers, persistent energy-price swings keep input costs unpredictable.

Other drivers and restraints analyzed in the detailed report include:

1. Stricter HAI Regulations Boosting Antimicrobial Uptake
2. Venture Funding in Smart Implants
3. Fragmented Regulatory Pathways for Nanocoatings

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Parylene coatings represented 29.10% of the medical coatings market in 2025. Their pin-hole-free conformal layers protect neural probes, pacemakers and microfluidic chips, underpinning long-term trust in critical implants. Demand remains stable in cardiology and neuromodulation, yet raw material scarcity and deposition cycle length put cost pressure on suppliers. Fluoropolymer solutions are experiencing a robust growth rate of 7.32% CAGR, driven by the demand for ultra-low friction in catheter procedures. Regulatory focus on PFAS limits heightens uncertainty, but healthcare exemptions expected for life-saving devices preserve outlook. Silicone-based chemistries retain relevance in flexible tubing and wound-care films due to elastomeric properties, while metal-ion and bioceramic coatings inhabit high-value niches for osseointegration.

The medical coatings market is witnessing formulation cross-pollination whereby parylene films gain hydrophilic top-coats and fluoropolymer layers adopt antimicrobial additives. Suppliers offering such hybrid stacks secure multi-year contracts with OEMs looking to shrink vendor lists. Advancements in atomic layer deposition allow angstrom-level control of titanium oxide nucleation on parylene, boosting barrier performance.

Antimicrobial layers accounted for 30.10% of the revenue share in 2025, driven by hospital mandates to curb biofilm formation. Silver-ion and antibiotic coatings demonstrate sustained pathogen-kill rates in joint replacements and central-line catheters, enhancing device safety. Hydrophilic/lubricious finishes are experiencing the fastest growth at a 7.74% CAGR, powered by neurovascular and peripheral interventions that require smooth navigation through tortuous anatomy.

Multi-effect formulations that merge antimicrobial and lubricious traits stand out, particularly for urinary catheters where infection and comfort both matter. Anti-thrombogenic chemistries play a significant role in applications such as cardiovascular grafts and ventricular assist devices. Drug-eluting options in the "Others" basket gain traction as controlled-release stents receive new approvals, yet cost remains a barrier to widespread uptake outside critical cardiovascular segments. OEMs now specify performance dashboards-coefficient of friction, log-reduction values, cytotoxicity scores-and expect coaters to meet targets across parameters, raising technical entry hurdles.

Complete Report Scope:

• By Chemistry
  • Silicone
  • Fluoropolymer
  • Parylene
  • Others (Metal-based (Ti, Ag, Au), Bio ceramics)
• By Coating Function Type
  • Antimicrobial
  • Hydrophilic/Lubricious
  • Anti-thrombogenic/Hemocompatible
  • Others (Drug-eluting, Radiopaque)
• By Deposition Technology
  • Chemical Vapor Deposition (CVD)
  • Plasma Spray
  • Dip and Spray
  • Others
• By Application
  • Medical Device
  • Implants (Orthopedic, Cardiovascular, Dental)
  • Surgical Instruments and Tools
  • Others
• By Geography
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • ASEAN Countries
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Russia
    • NORDIC Countries
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America retained the top spot with 34.10% of 2025 revenue, underpinned by robust reimbursement, rigorous FDA pathways and a concentration of multinational OEM headquarters. Hospital purchasing committees emphasize coatings that support infection-reduction metrics mandated by CMS, anchoring steady antimicrobial volumes. Canada's device export incentives and Mexico's contract-manufacturing clusters also stimulate regional growth.

Asia Pacific is the fastest mover at an 8.78% CAGR, driven by China's Made in China 2025 targets and rising procedure rates among aging populations. Domestic Chinese manufacturers integrate parylene and hydrophilic chemistries to close performance gaps with imported devices, while Japanese and South Korean firms pioneer sensor-integrated implants. India and ASEAN markets progress from basic silicone coatings toward advanced fluoropolymer friction-reduction as catheter labs proliferate.

Europe contributes a sizeable revenue pool but faces PFAS uncertainty that clouds fluoropolymer futures. Nonetheless, Germany's orthopedic clusters and Ireland's export-oriented device plants sustain investment in plasma and CVD lines. South America and the Middle East & Africa remain nascent yet promising; Brazil's tax incentives for implant factories and Saudi Arabia's Vision 2030 healthcare build-out elevate demand for coated orthopedic and cardiovascular products.

1. Abbott Laboratories - St. Jude Coatings
2. AST Products, Inc.
3. Axalta Coating Systems
4. Biocoat, Inc.
5. Covalon Technologies Ltd.
6. DSM
7. Freudenberg Medical
8. Harland Medical Systems
9. Hydromer, Inc.
10. Medicoat AG
11. Merit Medical Systems
12. Momentive Performance Materials
13. PPG Industries
14. Precision Coating Co.
15. Surmodics, Inc.
16. Wacker Chemie AG

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Awareness Regarding Advancement of Medical Treatments
  • 4.2.2 Sharp rise in single-use, minimally-invasive devices post-pandemic
  • 4.2.3 Stricter HAIs regulations driving antimicrobial adoption
  • 4.2.4 Surge in ambulatory surgical centers requiring low-friction coatings
  • 4.2.5 Venture funding into smart implant start-ups
• 4.3 Market Restraints
  • 4.3.1 Raw-material price volatility (silicones, parylene dimers)
  • 4.3.2 Complex, fragmented regulatory pathways for nanocoatings
  • 4.3.3 Supply-chain risks for specialty fluoropolymers
• 4.4 Value Chain Analysis
• 4.5 Porter's Five Forces
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Degree of Competition

5 Market Size and Growth Forecasts (Value)

• 5.1 By Chemistry
  • 5.1.1 Silicone
  • 5.1.2 Fluoropolymer
  • 5.1.3 Parylene
  • 5.1.4 Others (Metal-based (Ti, Ag, Au), Bio ceramics)
• 5.2 By Coating Function Type
  • 5.2.1 Antimicrobial
  • 5.2.2 Hydrophilic/Lubricious
  • 5.2.3 Anti-thrombogenic/Hemocompatible
  • 5.2.4 Others (Drug-eluting, Radiopaque)
• 5.3 By Deposition Technology
  • 5.3.1 Chemical Vapor Deposition (CVD)
  • 5.3.2 Plasma Spray
  • 5.3.3 Dip and Spray
  • 5.3.4 Others
• 5.4 By Application
  • 5.4.1 Medical Device
  • 5.4.2 Implants (Orthopedic, Cardiovascular, Dental)
  • 5.4.3 Surgical Instruments and Tools
  • 5.4.4 Others
• 5.5 By Geography
  • 5.5.1 Asia-Pacific
    • 5.5.1.1 China
    • 5.5.1.2 Japan
    • 5.5.1.3 India
    • 5.5.1.4 South Korea
    • 5.5.1.5 ASEAN Countries
    • 5.5.1.6 Rest of Asia-Pacific
  • 5.5.2 North America
    • 5.5.2.1 United States
    • 5.5.2.2 Canada
    • 5.5.2.3 Mexico
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Russia
    • 5.5.3.7 NORDIC Countries
    • 5.5.3.8 Rest of Europe
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Saudi Arabia
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 Abbott Laboratories - St. Jude Coatings
  • 6.4.2 AST Products, Inc.
  • 6.4.3 Axalta Coating Systems
  • 6.4.4 Biocoat, Inc.
  • 6.4.5 Covalon Technologies Ltd.
  • 6.4.6 DSM
  • 6.4.7 Freudenberg Medical
  • 6.4.8 Harland Medical Systems
  • 6.4.9 Hydromer, Inc.
  • 6.4.10 Medicoat AG
  • 6.4.11 Merit Medical Systems
  • 6.4.12 Momentive Performance Materials
  • 6.4.13 PPG Industries
  • 6.4.14 Precision Coating Co.
  • 6.4.15 Surmodics, Inc.
  • 6.4.16 Wacker Chemie AG

7 Market Opportunities and Future Outlook

• 7.1 White-space and Unmet-need Assessment